TY  - JOUR
AU  - Jimenez-Rodriguez, Begona 
AU  - Diaz-Cordoba, Gema 
AU  - Garrido-Aranda, Alicia 
AU  - Alvarez, Martina
AU  - Vicioso, Luis
AU  - Llacer-Perez, Casilda
AU  - Hernando, Cristina
AU  - Bermejo, Begoña
AU  - Julve-Parreño, Ana 
AU  - Lluch, Ana
AU  - Ryder, Matthew B
AU  - Jones, Frederick S
AU  - Fredebohm, Johannes
AU  - Holtrup, Frank
AU  - Queipo-Ortuño, Maria Isabel
AU  - Alba, Emilio
PY  - 2019
DO  - 10.3390/jcm8081183
SN  - 2077-0383
UR  - http://hdl.handle.net/10668/14381
T2  - Journal of clinical medicine
AB  - Circulating tumor DNA (ctDNA) has emerged as a non-invasive "liquid biopsy" for early breast cancer diagnosis. We evaluated the suitability of ctDNA analysis in the diagnosis of early breast cancer after mammography findings, comparing PIK3CA and TP53...
LA  - en
PB  - MDPI
KW  - Breast cancer
KW  - Circulating tumor DNA (ctDNA)
KW  - Early-stage cancer
KW  - Liquid biopsy
KW  - Molecular profiling
KW  - Circulating Tumor DNA
KW  - Cell-Free Nucleic Acids
KW  - Liquid Biopsy
KW  - Hematologic Diseases
KW  - Mutation
KW  - Mammography
KW  - Lymph Nodes
TI  - Detection of TP53 and PIK3CA Mutations in Circulating Tumor DNA Using Next-Generation Sequencing in the Screening Process for Early Breast Cancer Diagnosis.
TY  - research article
VL  - 8
ER  -